Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 431-439

  Rabbat, Christian G ^a   Treleaven, Darin J ^a   Russell, J David ^a   Ludwin, David ^a   Cook, Deborah J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; HEART DEATH; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDLINE; META ANALYSIS; PANCREAS TRANSPLANTATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL RISK;

EID: 0037307506     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000047560.51444.3A     Document Type: Article

References (41)

1. US Renal Data System: Appendix H, Mortality and causes of death, In: USRDS 2000 Annual Data Report, Bethesda, MD, National Institutes of Health National Institute of Diabetes, Digestive, Kidney Diseases, 2000, pp 659
2. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9: S16-S23, 1998
3. US Renal Data System: Patient characteristics at the beginning of ESRD, In: USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes, Digestive, Kidney Diseases, 2001, p58
4. US Renal Data System: Cardiovascular special studies, In: USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes, Digestive, Kidney Diseases, 2001, p153
5. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339: 799-805, 1998
6. Kasiske BL, Ramos EL, Gaston RS, Bia MJ, Danovitch GM, Bowen PA, Lundin PA, Murphy KJ: The evaluation of renal transplant candidates: Clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 6: 1-34, 1995
7. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, Rush DN, Vazquez MA, Weir MR: The evaluation of renal transplantation candidates: Clinical practice guidelines. Am J Transplant 1[Suppl 2]: 1-95, 2002
8. Herzog CA: Diagnosis and treatment of ischemic heart disease in dialysis patients. Curr Opin Nephrol Hypertens 6: 558-565, 1997
9. de Lemos JA, Hillis LD: Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 7: 2044-2054, 1996
10. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 44: 617-621, 1993
11. Lewis MS, Wilson RA, Walker K, Stegeman-Olsen J, Norman DJ, Barry JM, Bennett WM: Factors in cardiac risk stratification of candidates for renal transplant. Journal of Cardiovascular Risk 6: 251-255, 1999
12. Le A, Wilson R, Douek K, Pulliam L, Tolzman D, Norman D, Barry J, Bennett W: Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 24: 65-71, 1994
13. Laupacis A, Wells G, Richardson WS, Tugwell P: Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 272: 234-237, 1994
14. Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res 2: 121-145, 1993
15. Cucherat M: EasyMA 2000, Lyon, France, 1997
16. Mistry BM, Bastani B, Solomon H, Hoff J, Aridge DL, Lindsey LM, Schmid S, Chaitman BR, Garvin PJ: Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin Transplant 12: 130-135, 1998
17. Biggerstaff BJ, Tweedie RL: Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med 16: 753-768, 1997
18. Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SL, Chaitman BR: Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 65: 1459-1463, 1990
19. Iqbal A, Gibbons RJ, McGoon MD, Sterioff S, Frohnert PP, Velosa JA: Noninvasive assessment of cardiac risk in insulin-dependent diabetic patients being evaluated for pancreatic transplantation using thallium-201 myocardial perfusion scintigraphy. Clin Transplant 5: 13-19, 1991
20. Vandenberg BF, Rossen JD, Grover-McKay M, Shammas NW, Burns TL, Rezai K: Evaluation of diabetic patients for renal and pancreas transplantation: Noninvasive screening for coronary artery disease using radionuclide methods. Transplantation 62: 1230-1235, 1996
21. Bates JR, Sawada SG, Segar DS, Spaedy AJ, Petrovic O, Fineberg NS, Feigenbaum H, Ryan T: Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 77: 175-179, 1996
22. Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Go RT, Swift C, Braun WE: Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 49: 100-103, 1990
23. Brennan DC, Vedala G, Miller SB, Anstey ME, Singer GG, Kovacs A, Barzilai B, Lowell JA, Shenoy S, Howard TK, Davila-Roman VG: Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates. Transplant Proc 29: 233-234, 1997
24. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD: Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kid Dis 33: 1080-1090, 1999
25. Marwick TH, Lauer MS, Lobo A, Nally J, Braun W: Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 244: 155-161, 1998
26. Brown JH, Vites NP, Testa HJ, Prescott MC, Hunt LP, Gokal R, Mallick NP: Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 8: 433-437, 1993
27. Brown KA, Rimmer J, Haisch C: Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 64: 1017-1021, 1989
28. Reis G, Marcovitz PA, Leichtman AB, Merion RM, Fay WP, Werns SW, Armstrong WF: Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 75: 707-710, 1995
29. Welsh RC, Cockfield S, Halloran PF, Campbell P, Taylor D: Nonivasive cardiac assessment of diabetic nephropathy renal transplant candidates [abstract]. J Am Coll Cardiol 33: 335A, 1999
30. Philipson JD, Carpenter BJ, Itzkoff J, Hakala TR, Rosenthal JT, Taylor RJ, Puschett JB: Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81: 630-634, 1986
31. Holley JL, Fenton RA, Arthur RS: Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 90: 563-570, 1991
32. Morrow CE, Schwartz JS, Sutherland DE, Simmons RL, Ferguson RM, Kjellstrand CM, Najarian JS: Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 146: 331-335, 1983
33. Jaeschke R, Guyatt G, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 271: 389-391, 1994
34. Manske CL, Wang Y, Rector T, Wilson RF, White CW: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340: 998-1002, 1992
35. Herzog CA, Ma JZ, Collins AJ: Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 56: 324-332, 1999
36. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793-801, 2002
37. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024-2031, 1995
38. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
39. Rabbat CG, Lambert K, Stanton EB, Churchill DN, Russell JD: Long term prognostic significance of clinical risk stratification and myocardial perfusion studies in patients assessed for renal transplantation [Abstract]. Am J Transplant 1: 378, 2001
40. Shaw LJ, Eagle KA, Gersh BJ, Miller DD: Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 27: 787-798, 1996
41. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49: 1428-1434, 1996